谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

P134 MK-5684-003: A Randomized, Phase 3 Study of CYP11A1 Inhibitor Ppevesostat (MK- 5684) Versus Next-Generation Hormonal Agent (NHA) Switch in Patients with Metastatic Castration-Resistant Prostate Cancer (mcrpc) after NHA and Taxane-Based Chemotherapy

Yu E., Song Y.,Garratt C.,Poehlein C.,Schloss C.,Antonarakis E.S.

European Urology Open Science（2024）

引用 0|浏览1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要